Reviews of White Market Drugs
“[Herzberg has a] fantastic eye for politically led motives. . . [he] provides brilliant lessons on white-market policy.” ― The British Journal for the History of Science
“Herzberg understands markets.” ― Regulation
“What Herzberg does best is put flesh on the bones of drug consumers on both sides of the great divide—teaching us that the vast majority of drug users are white, middle-class consumers in the midst of the ‘white market apocalypse. ― Journal of Social History
"Herzberg’s masterful book . . . brings together novel theoretical framing, profound policy analysis, and attention to the narratives of those most intimately affected by these policies. He offers a promising framework to address the many challenges in our current drug policies. Policymakers would be well served to take notice of this book." ― Journal of the History of Medicine and Allied Sciences
“At the start of White Market Drugs, Herzberg laments that ‘pharmaceutical opioids do not yet have their historian.’ They do now. He has presented a careful and comprehensive chronicle spanning more than a century.” ― Wall Street Journal
“Herzberg’s White Markets reminds us that over the last 150 years, pharmaceutical boom and bust cycles have continually hit small towns and communities across America.” ― New Republic
“White Market Drugs examin[es] the troubled history of psychoactive drugs in America. Herzberg considers licit and illicit drugs together, arguing that the marketing of medicine relies on the stigmatization and criminalization of those who consume drugs outside the medical system; the development of America’s gargantuan pharmaceutical markets must be understood alongside the growth of the illicit drug market. His choice of the phrase ‘white market’ to describe pharmaceuticals reflects the racial bias that has been baked into this system from the start.” ― Dissent
“Herzberg traces historical shifts from medicalization to criminalization and back. He carefully outlines the multiple factors that led to reckless opioid prescribing around the turn of the millennium and . . . argues effectively for policies to limit the distorting effect of profit-motivated drug provision. This could include everything from decriminalizing illicit drugs to nationalizing Big Pharma: turning drug companies into public utilities.” ― The Globe and Mail
"Herzberg argues that the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs—i.e., medicine—are sold to a largely white clientele. He advocates for a consumer protection approach that regulates all drug markets while caring for people with addiction by ensuring they have safe, reliable access to medication-assisted treatment. Accomplishing this, Herzberg explains, would require rethinking a racially segregated drug/medicine divide." One of the "Big Indie Books of Fall 2020"― Publishers Weekly
"An important book for casting a well-studied slice of history in a new light." -- American Historical Review
“White Market Drugs provides essential backstory for a string of Pharma-stoked drug crises. Reading Herzberg, you can see the prescription opioid addiction epidemic coming from a mile away. This book is a powerful prequel to the body of investigative reporting on what now seems like the worst scandal in US medical history.” -- David T. Courtwright, author of Dark Paradise and The Age of Addiction
“David Herzberg’s White Market Drugs is a fantastic book that tells the history of addictive pharmaceuticals in the United States since the late 19th century through the current ‘twin crises’ of opioid addiction and mass incarceration of racial minorities. It is the first book to provide a comprehensive history of addictive pharmaceuticals and show how imbricated that history is within the broader history of addiction, drug policy, and health care in America.” -- Dominique Tobbell, author of Pills, Power, and Policy: The Struggle for Drug Reform in Cold War America and Its Consequences
"In this sweeping analysis of a century of US drug policy, Herzberg asks why our clinical, carceral, public health, and police responses to addictive substances have hinged on the false dichotomy between dangerous drugs and legitimate pharmaceuticals—and shows how this distinction has always had more to do with the politics of respectability than any underlying principles of pharmacology. Meticulously researched and clearly written, White Market Drugs provides not only an indictment of the failures of the present but also a roadmap for reducing harm in the future: a must-read for all concerned with the human toll of America’s long and costly wars on drugs." -- Jeremy Greene, author of Generic: The Unbranding of Modern Medicine
Media:
